Parameter | CC group (n = 41) | Control group (n = 24) | ||||||
---|---|---|---|---|---|---|---|---|
Baseline | After two months of CC stimulation | Delta | p | Baseline | After two months | Delta | p | |
LH (mU/mL) | 11.8 ± 4.9 | 10.9 ± 4.0 | −0.9 ± 2.8 | 0.029 | 13.0 ± 6.0 | 12.3 ± 5.5 | − 0.68 ± 2.4 | 0.174 |
FSH (mU/mL) | 5.9 ± 1.8 | 5.9 ± 1.4 | 0.1 ± 1.5 | 0.787 | 6.2 ± 1.5 | 5.5 ± 1.2 | − 0.64 ± 1.7 | 0.072 |
LH:FSH ratio | 2.1 ± 0.8 | 1.8 ± 0.5 | − 0.2 ± 0.6 | 0.007 | 2.1 ± 0.8 | 2.1 ± 0.8 | −0.05 ± 0.6 | 0.643 |
Total testosterone (ng/mL) | 0.43 ± 0.15 | 0.43 ± 1.55 | 0.02 ± 0.11 | 0.651 | 0.44 ± 0.15 | 0.46 ± 0.12 | 0.02 ± 0.08 | 0.223 |
Free testosterone (ng/mL) | 0.30 ± 0.21 | 0.27 ± 0.18 | −0.03 ± 0.14 | 0.314 | 0.30 ± 0.19 | 0.26 ± 0.12 | −0.03 ± 0.14 | 0.241 |
Androstenedione (ng/mL) | 2.77 ± 1.25 | 3.23 ± 1.11 | 0.29 ± 0.76 | 0.216 | 3.01 ± 1.13 | 2.97 ± 0.93 | −0.04 ± 0.80 | 0.801 |
SHBG (nmol/L) | 46.0 ± 20.2 | 51.2 ± 21.0 | 5.2 ± 5.7 | < 0.001 | 44.2 ± 27.3 | 43.0 ± 22.0 | −1.2 ± 8.5 | 0.500 |
AMH (ng/mL) | 8.08 ± 4.27 | 7.17 ± 3.37 | −0.9 ± 2.1 | 0.011 | 8.07 ± 4.25 | 7.97 ± 4.18 | −0.10 ± 1.1 | 0.654 |